Serveur d'exploration sur la maladie de Parkinson

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Arrhythmias in the Wolff-Parkinson-White syndrome

Identifieur interne : 002D43 ( Main/Exploration ); précédent : 002D42; suivant : 002D44

Arrhythmias in the Wolff-Parkinson-White syndrome

Auteurs : Bertram J. Newman ; Ephraim Donoso ; Charles K. Friedberg

Source :

RBID : ISTEX:77A81CC429EEC67507A6B79AB0AF19C8512F4DC6

Abstract

The incidence of the WPW anomaly in adults ranges from 0.1 to 3.1 per thousand and in children from 0.77 to 4.8 per thousand. Acquired heart disease as well as many congenital cardiac defects are associated with the WPW anomaly. Sixty to 70 per cent of patients demonstrating this pattern are males.Arrhythmias occur in about 40 to 80 per cent of patients, and tend to reoccur. The most common arrhythmia is atrial tachycardia. Atrial fibrillation and flutter are also seen. There is a high incidence of rapid ventricular rate with aberration in conduction in response to these arrhythmias (30 per cent). This rapid aberrant ventricular response may be confused with ventricular tachycardia and the criteria for diagnosis are described.Quinidine has been used to terminate the arrhythmias associated with the WPW syndrome. Although the use of digitalis in these arrhythmias has not achieved widespread acceptance, it should be employed as it is in situations not complicated by the WPW anomaly. Combination therapy with digitalis and quinidine has been successful in refractory cases. Electrical cardioversion has also been employed. There should be no deley in instituting therapy since several instances of death have been reported during the acute attacks. Prophylactic use of quinidine is indicated when attacks tend to recur and are severe.The prognosis of the individual patient is affected by the presence or absence of underlying heart disease, age at onset of tachycardia, tendency for recurrence and duration and severity of the single episodes.

Url:
DOI: 10.1016/S0033-0620(66)80003-8


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Arrhythmias in the Wolff-Parkinson-White syndrome</title>
<author>
<name sortKey="Newman, Bertram J" sort="Newman, Bertram J" uniqKey="Newman B" first="Bertram J." last="Newman">Bertram J. Newman</name>
</author>
<author>
<name sortKey="Donoso, Ephraim" sort="Donoso, Ephraim" uniqKey="Donoso E" first="Ephraim" last="Donoso">Ephraim Donoso</name>
</author>
<author>
<name sortKey="Friedberg, Charles K" sort="Friedberg, Charles K" uniqKey="Friedberg C" first="Charles K." last="Friedberg">Charles K. Friedberg</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:77A81CC429EEC67507A6B79AB0AF19C8512F4DC6</idno>
<date when="1966" year="1966">1966</date>
<idno type="doi">10.1016/S0033-0620(66)80003-8</idno>
<idno type="url">https://api.istex.fr/document/77A81CC429EEC67507A6B79AB0AF19C8512F4DC6/fulltext/pdf</idno>
<idno type="wicri:Area/Main/Corpus">000007</idno>
<idno type="wicri:Area/Main/Curation">000007</idno>
<idno type="wicri:Area/Main/Exploration">002D43</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Arrhythmias in the Wolff-Parkinson-White syndrome</title>
<author>
<name sortKey="Newman, Bertram J" sort="Newman, Bertram J" uniqKey="Newman B" first="Bertram J." last="Newman">Bertram J. Newman</name>
</author>
<author>
<name sortKey="Donoso, Ephraim" sort="Donoso, Ephraim" uniqKey="Donoso E" first="Ephraim" last="Donoso">Ephraim Donoso</name>
</author>
<author>
<name sortKey="Friedberg, Charles K" sort="Friedberg, Charles K" uniqKey="Friedberg C" first="Charles K." last="Friedberg">Charles K. Friedberg</name>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Progress in Cardiovascular Diseases</title>
<title level="j" type="abbrev">YPCAD</title>
<idno type="ISSN">0033-0620</idno>
<imprint>
<publisher>ELSEVIER</publisher>
<date type="published" when="1966">1966</date>
<biblScope unit="volume">9</biblScope>
<biblScope unit="issue">2</biblScope>
<biblScope unit="page" from="147">147</biblScope>
<biblScope unit="page" to="165">165</biblScope>
</imprint>
<idno type="ISSN">0033-0620</idno>
</series>
<idno type="istex">77A81CC429EEC67507A6B79AB0AF19C8512F4DC6</idno>
<idno type="DOI">10.1016/S0033-0620(66)80003-8</idno>
<idno type="PII">S0033-0620(66)80003-8</idno>
<idno type="ArticleID">66800038</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0033-0620</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass></textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The incidence of the WPW anomaly in adults ranges from 0.1 to 3.1 per thousand and in children from 0.77 to 4.8 per thousand. Acquired heart disease as well as many congenital cardiac defects are associated with the WPW anomaly. Sixty to 70 per cent of patients demonstrating this pattern are males.Arrhythmias occur in about 40 to 80 per cent of patients, and tend to reoccur. The most common arrhythmia is atrial tachycardia. Atrial fibrillation and flutter are also seen. There is a high incidence of rapid ventricular rate with aberration in conduction in response to these arrhythmias (30 per cent). This rapid aberrant ventricular response may be confused with ventricular tachycardia and the criteria for diagnosis are described.Quinidine has been used to terminate the arrhythmias associated with the WPW syndrome. Although the use of digitalis in these arrhythmias has not achieved widespread acceptance, it should be employed as it is in situations not complicated by the WPW anomaly. Combination therapy with digitalis and quinidine has been successful in refractory cases. Electrical cardioversion has also been employed. There should be no deley in instituting therapy since several instances of death have been reported during the acute attacks. Prophylactic use of quinidine is indicated when attacks tend to recur and are severe.The prognosis of the individual patient is affected by the presence or absence of underlying heart disease, age at onset of tachycardia, tendency for recurrence and duration and severity of the single episodes.</div>
</front>
</TEI>
<affiliations>
<list></list>
<tree>
<noCountry>
<name sortKey="Donoso, Ephraim" sort="Donoso, Ephraim" uniqKey="Donoso E" first="Ephraim" last="Donoso">Ephraim Donoso</name>
<name sortKey="Friedberg, Charles K" sort="Friedberg, Charles K" uniqKey="Friedberg C" first="Charles K." last="Friedberg">Charles K. Friedberg</name>
<name sortKey="Newman, Bertram J" sort="Newman, Bertram J" uniqKey="Newman B" first="Bertram J." last="Newman">Bertram J. Newman</name>
</noCountry>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002D43 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002D43 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:77A81CC429EEC67507A6B79AB0AF19C8512F4DC6
   |texte=   Arrhythmias in the Wolff-Parkinson-White syndrome
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024